Ventricular Assist Device Market

Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.

A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.

Ventricular Assist Device Market contains market size and forecasts of Ventricular Assist Device in global, including the following market information:

Global Ventricular Assist Device Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Ventricular Assist Device Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Ventricular Assist Device companies in 2021 (%)

The global Ventricular Assist Device market was valued at 1359.9 million in 2021 and is projected to reach US$ 2297.1 million by 2028, at a CAGR of 7.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

LVADs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ventricular Assist Device include AbioMed, Abbott (Thoratec), Medtronic (HeartWare) and Berlin Heart, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ventricular Assist Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ventricular Assist Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ventricular Assist Device Market Segment Percentages, by Type, 2021 (%)

LVADs

RVADs

BIVADs

Global Ventricular Assist Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ventricular Assist Device Market Segment Percentages, by Application, 2021 (%)

Bridge-to-transplant (BTT)

Destination Therapy (DT)

Other

Global Ventricular Assist Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Ventricular Assist Device Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ventricular Assist Device revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Ventricular Assist Device revenues share in global market, 2021 (%)

Key companies Ventricular Assist Device sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Ventricular Assist Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AbioMed

Abbott (Thoratec)

Medtronic (HeartWare)

Berlin Heart